Discover Tenders by Non Decaffeinated Coffee Sector

Find the most relevant tenders for Non Decaffeinated Coffee. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Decaffeinated Coffee tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Decaffeinated Coffee tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Sulfasalazine Atc Code M01Cx02

Deadline: 27 May 2026

Germany

Ref. No.: 6276041

EMD:Ref Document

Bid Value: Ref Document

250 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Desloratadine R06Ax27 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6275277

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Colistin J01Xb01 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6263369

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Goserelin L02Ae03 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6262066

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Nadroparin B01Ab06 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6261693

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6261602

EMD:Ref Document

Bid Value: Ref Document

468 Days Left

Food And Beverage Coffee

Deadline: 30 Jun 2027

Australia

Ref. No.: 6235349

EMD:Ref Document

Bid Value: Ref Document

649 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alitretinoin D11Ah04 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6230493

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Dolutegravir And Rilpivirine J05Ar21 Within The Framework Of A So Called Open House

Deadline: 31 May 2026

Germany

Ref. No.: 6229869

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Deadline: 31 Dec 2026

Germany

Ref. No.: 6229837

EMD:Ref Document

Bid Value: Ref Document

468 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab C10Ax14 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6227129

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Bempedoic Acid C10Ax15 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6227068

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lisdexamfetamine N06Ba12 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6225281

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Etanercept L04Ab01 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6224846

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ustekinumab L04Ac05 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6224416

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Showing 24421 to 24435 of 24786 results

‹
1
2
...
1626
1627
1628
1629
1630
1631
1632
...
1652
1653
›

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

FREE Trial plan for all new users!